Question 763
{"accessible":false,"alternatives":[{"id":3872,"text":"dimethyl fumarate"},{"id":3873,"text":"fingolimod"},{"id":3874,"text":"interferon beta"},{"id":3875,"text":"mitoxantrone"},{"id":3876,"text":"natalizumab"},{"id":3877,"text":"teriflunomide"}],"archived":false,"correctAlternativeId":3876,"explanation":"\u003cp\u003ePML in MS is particularly seen in patients treated with natalizumab with positive JC virus serology.\u003c/p\u003e","id":763,"imageUrl":null,"imageAttribution":null,"imageAttributionCaseInfo":null,"firstQuestionPath":"/questions/2590","nextQuestionPath":"/articles/multiple-sclerosis/questions/507","relatedArticles":[{"id":12098,"title":"Progressive multifocal leukoencephalopathy","link":"/articles/progressive-multifocal-leukoencephalopathy?lang=us"}],"alsoUsedIn":[],"stem":"\u003cp\u003eWhich of the following treatments for multiple sclerosis is most closely associated with the development of progressive multifocal leukoencephalopathy (PML)?\u003c/p\u003e","menuLinks":[{"text":"Report problem with question","url":"https://docs.google.com/forms/d/e/1FAIpQLSfO3soWYhOjJ7yErSysyCe5V4A1CqW7WK3rDA7MtAkecMGqNw/viewform?entry.1624461248\u0026entry.553583435=https://radiopaedia.org/questions/763"}],"attemptsPercentages":[{"alternativeId":"3874","percentage":10},{"alternativeId":"3873","percentage":2},{"alternativeId":"3877","percentage":2},{"alternativeId":"3876","percentage":79},{"alternativeId":"3875","percentage":6},{"alternativeId":"3872","percentage":1}],"promptToLogin":false,"questionManager":false,"articleId":"multiple-sclerosis"}